首页> 外国专利> Compositions of RNAi against factor XII (Hageman factor) (F12), calicreu00cdna B, PLASMu00c1TICA (factor 1 (Fletcher), and quininu00d3geno Klkb1) 1 (kng1) and Methods of Use thereof

Compositions of RNAi against factor XII (Hageman factor) (F12), calicreu00cdna B, PLASMu00c1TICA (factor 1 (Fletcher), and quininu00d3geno Klkb1) 1 (kng1) and Methods of Use thereof

机译:抗因子XII(Hageman因子)(F12),calicre u00cdna B,PLASM u00c1TICA(因子1(Fletcher)和quinin u00d3geno Klkb1)1(kng1)的RNAi的组成及其使用方法

摘要

This is related to RNAi agents, for example, agents of RNAi against Double stranded b gene, plasma kallikrein, factor (Fletcher) 1 (Klkb1), The Gene of factor XII (Hageman factor (F12), or quininu00f3geno Gene 1 (kng1), and Methods of use these Agents for RNAi Inhibit the expression of a Gene, a Gene Klkb1, F12, and / or a Gene kng1,And Methods for treating subjects with Hereditary angioedema (HAE) and / or a disorder associated with Channel Activation by contact. Cell, vector, Pharmaceutical composition.
机译:这与RNAi试剂有关,例如针对双链b基因,血浆激肽释放酶,因子(Fletcher)1(Klkb1),因子XII的基因(Hageman因子(F12)或quinin u00f3geno基因1( kng1),以及这些试剂用于RNAi的方法抑制基因,基因Klkb1,F12和 /或基因kng1的表达,以及治疗患有遗传性血管性水肿(HAE)和//或相关疾病的受试者的方法通过接触激活通道,细胞,载体,药物成分。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号